Adjuvant imatinib treatment improves recurrence-free survival in patients with high-risk gastrointestinal stromal tumours (GIST)

por Nilsson, B, Sjölund, K, Kindblom, L-G, Meis-Kindblom, J M, Bümming, P, Nilsson, O, Andersson, J, Ahlman, H
Publicado 2007

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

por Bümming, P, Andersson, J, Meis-Kindblom, J M, Klingenstierna, H, Engström, K, Stierner, U, Wängberg, B, Jansson, S, Ahlman, H, Kindblom, L-G, Nilsson, B
Publicado 2003